12 Health Care Stocks Moving In Monday's After-Market Session

Gainers

  • Agape ATP ATPC shares rose 23.0% to $0.32 during Monday's after-market session. The market value of their outstanding shares is at $24.9 million.
  • FibroGen FGEN shares increased by 20.68% to $1.4. The market value of their outstanding shares is at $139.2 million. As per the news, the Q1 earnings report came out today.
  • RxSight RXST shares rose 11.39% to $70.0. The company's market cap stands at $2.6 billion. As per the news, the Q1 earnings report came out today.
  • Innovative Eyewear LUCY shares increased by 10.81% to $0.25. The market value of their outstanding shares is at $3.2 million.
  • Hims & Hers Health HIMS shares increased by 10.72% to $12.9. The company's market cap stands at $2.7 billion. As per the press release, Q1 earnings came out today.
  • iSpecimen ISPC stock increased by 8.58% to $0.3. The company's market cap stands at $2.7 million.

Losers

  • Predictive Oncology POAI shares decreased by 9.1% to $1.6 during Monday's after-market session. The market value of their outstanding shares is at $6.5 million.
  • SI-BONE SIBN shares fell 6.77% to $13.5. The company's market cap stands at $556.2 million. As per the news, the Q1 earnings report came out today.
  • Anitra AZTR stock fell 5.68% to $0.25. The company's market cap stands at $7.2 million.
  • Ontrak OTRK stock declined by 5.28% to $0.24. The market value of their outstanding shares is at $11.2 million.
  • Clene CLNN shares declined by 5.15% to $0.4. The company's market cap stands at $51.6 million.
  • Regulus Therapeutics RGLS shares fell 4.96% to $2.3. The market value of their outstanding shares is at $150.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!